In the current study, we used flow cytometry to examine the circulating monocytes in particular CD16+ monocytes and other markers of monocyte activation such as 27E10, 25F9, CD68, and CD11b, in two groups of diabetic subjects with an equally long duration of diabetes but which differ by the presence or absence of clinically significant diabetic complications. The gene discussed is CD68; the disease is diabetes mellitus.